Equity valuations, Tesla’s capital raise, watch US tech earnings

Equities 5 minutes to read

Peter Garnry

Head of Equity Strategy

Summary:  The rally in equities has taken equity valuations to the highest levels since October 2000 setting the equity market up for a high-risk period during the months of October and November with Q3 earnings and the US election. Tesla announced yesterday a $5bn capital raise to strengthen the balance sheet and support growth which makes a lot of sense given how little the $5bn dilute the existing shareholders. Finally, we are zooming in on five US technology earnings tonight after the US close with a lot of anticipation and speculation in especially MongoDB shares.


The relentless rally in global equities driven by the technology and health care sector has pushed equity valuation on the MSCI World Index to 1.31 standard deviations above the average since 1995. This is the highest level since October 2000. The jump in valuation is naturally driven by the combination of collapsing earnings and cash flows, and the strong bet on a sharp rebound in economic activity. This means that the Q3 earnings in October and November will be crucial for the equity market. The earnings season happens to collide with this year’s US election setting the market up for a high-risk period over this two-month period. The October monthly contract on VIX futures has moved up to 33.4 which is a quite elevated level for expected volatility.

Back on July 8 we tweeted that Elon Musk, the CEO of Tesla, should consider taking advantage of the high equity valuations of Tesla’s shares and issue equity capital to accelerate growth even further.

Source: Twitter

Less than two months following our thoughts Tesla announced an equity distribution pact worth $5bn meaning that the company can issue new shares “from time to time” with the intention to use the proceeds to strengthen its balance sheet and fund growth. The world’s leading EV-maker is expanding rapidly having just finished a manufacturing plant in Shanghai and is expanding with new factories in Germany and Texas. The news caused its shares to decline by almost 5% yesterday which is significantly above the dilution effect from the new shares. In the option market a lot of activity is still visible on the $500 strikes with heavy call option volume on the expiration date on Thursday. This means that today’s price action will even more exciting.

Source: Saxo Group

Today a small group of US technology companies will report earnings after the close. The companies are Crowdstrike, Copart, MongoDB, Guidewire and Smartsheet. What we have observed over the past couple of weeks is that US technology companies reporting earnings have seen speculative rallies into the releases, so potential behaviour could happen again in today’s session. Of the companies reporting today especially MongoDB stands out with a 31% rally since 10 August. It seems investors are betting heavily that analyst estimates are way off expecting revenue only to grow 28% from a year ago following a 46% growth in FY21 Q1 (ending on 30 April) which showed robust revenue generation despite COVID-19.

Source: Bloomberg
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.